Utility of oncotype in premenopausal women with hormonal receptor (hr) positive her2 negative early breast cancer

Cudós, AG; Murillo, SM; Der-Abrain, NT; Guzmán, DRS; Villellas, FV; Orillo, EMM; Morales, CC; Olivé, JM; Cid, LA

BREAST, 2023; 68 (): S19